Dr. Gozani is the Morris Herzstein Professor in the Department of Biology at Stanford University. Since starting his group, over 50 PhD PhD students and post-doctoral fellows have trained or are presently training in the Gozani lab. Insights and discoveries made by members of the Gozani lab have uncovered pivotal roles for protein methylation in the regulation of chromatin biology, epigenetics, mRNA translation, and cell signaling in human health and disease. Dr. Gozani received his BA in molecular biology at UC Berkeley and his MD and PhD degrees from Harvard Medical School. Dr. Gozani completed his post-doctoral training at Harvard Medical School. Dr. Gozani is a scientific co-founder of EpiCypher, Inc, K36 Therapeutics, Inc., and ABio Therapeutics, Inc.